Regenerative Medicine and Tissue Engineering - Cells and Biomaterials 2011
DOI: 10.5772/21790
|View full text |Cite
|
Sign up to set email alerts
|

The Fibrotic Response to Implanted Biomaterials: Implications for Tissue Engineering

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
53
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 45 publications
(53 citation statements)
references
References 127 publications
0
53
0
Order By: Relevance
“…35,53,56 Although, increased porosity may be beneficial as this tends to correlate with increased vascularity. 44,48 It’s also possible that a patient’s local and systemic inflammatory status may significantly affect bone outcomes as IL6 was elevated in the micro-roughed groups and lead to fewer unions. There are very many possible avenues for future research on the Masquelet Technique that are directly translatable to clinical application.…”
Section: Discussionmentioning
confidence: 99%
“…35,53,56 Although, increased porosity may be beneficial as this tends to correlate with increased vascularity. 44,48 It’s also possible that a patient’s local and systemic inflammatory status may significantly affect bone outcomes as IL6 was elevated in the micro-roughed groups and lead to fewer unions. There are very many possible avenues for future research on the Masquelet Technique that are directly translatable to clinical application.…”
Section: Discussionmentioning
confidence: 99%
“…Transforming growth factor beta (TGF-β) is one of the main factors responsible for promoting fibroblast proliferation and subsequent collagen deposition by these cells during wound healing (28), and is produced by different cell types including macrophages and epithelial cells (46). Aprotinin has been shown to completely inhibit the activation of TGF-β, and therefore reduce tissue fibrosis and capsule formation in vivo (46, 47). Therefore, a potential explanation for the reduced fibrous capsule thickness observed surrounding our aprotinin implants is the interaction of aprotinin with TGF-β activation via this pathway, resulting in decreased collagen deposition by fibroblasts.…”
Section: Discussionmentioning
confidence: 99%
“…In addition to their role in diseases like cystic fibrosis, NETs have also been shown to accumulate on sterile implant materials . Such fibrosis‐triggering cell products can initiate an impaired efficiency of the implant or even device failure . One possibility for reducing the adhesion of neutrophils and subsequent NET production on implants is to coat the implant surfaces with mucins .…”
Section: Introductionmentioning
confidence: 99%